INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
PATIENT REVENUES, net	$ 141,431	$ 146,377	$ 423,798	$ 430,427
EXPENSES:
Operating	113,799	118,104	337,517	341,937
Lease and rent expense	13,764	13,791	41,202	41,297
Professional liability	2,933	2,617	8,890	8,011
Litigation contingency expense (Note 6)	6,400	0	6,400	0
General and administrative	7,537	8,083	24,971	25,277
Depreciation and amortization	2,964	2,988	8,692	8,095
Lease termination receipts	0	(180)	0	(180)
Total expenses	147,397	145,403	427,672	424,437
OPERATING INCOME (LOSS)	(5,966)	974	(3,874)	5,990
OTHER INCOME (EXPENSE):
Gain on sale of investment in unconsolidated affiliate			308	733
Other income	36	0	115	0
Interest expense, net	(1,666)	(1,668)	(4,996)	(4,692)
Hurricane costs	0	(232)	0	(232)
Total other expense	(1,630)	(1,900)	(4,573)	(4,191)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(7,596)	(926)	(8,447)	1,799
BENEFIT FOR INCOME TAXES	207	345	670	(651)
LOSS FROM CONTINUING OPERATIONS	(7,389)	(581)	(7,777)	1,148
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
Operating loss, net	(8)	1	(34)	(42)
NET LOSS	$ (7,397)	$ (580)	$ (7,811)	$ 1,106
Per common share – basic
Continuing operations (in dollars per share)	$ (1.15)	$ (0.09)	$ (1.22)	$ 0.18
Discontinued operations (in dollars per share)	0.00	0.00	(0.01)	(0.01)
Net income (loss) per common share – basic (dollars per share)	(1.15)	(0.09)	(1.23)	0.17
Per common share – diluted
Continuing operations (in dollars per share)	(1.15)	(0.09)	(1.22)	0.18
Discontinued operations (in dollars per share)	0.00	0.00	(0.01)	(0.01)
Net income (loss) per common share – diluted (dollars per share)	(1.15)	(0.09)	(1.23)	0.17
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (dollars per share)	$ 0.055	$ 0.055	$ 0.165	$ 0.165
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,400	6,294	6,362	6,274
Diluted (shares)	6,400	6,294	6,362	6,465